Sino-Japanese Journalist Exchange Agreement

Branded Legacy, Inc. Reduces Issued and Outstanding Shares By 46%

Retrieved on: 
Monday, August 15, 2022
CBDX, Vitamin, Share repurchase, Injury, Inflammation, Forward-looking statement, GLOBE, Mineral, Technology, Sleep, Private Securities Litigation Reform Act, Quick response manufacturing, BLEG, LLC, Brand legacy, Method, Marketing, Sino-Japanese Journalist Exchange Agreement, Engineering, Company, Spike, Acquisition, Ageing, Athlete, CBD, Organic acid, OTCQB, Quickness, Antioxidant, OTC Markets Group, NMN, Coffee, Risk management, Dietary supplement

The Company has been working over the last couple of weeks to reduce its issued and outstanding shares.

Key Points: 
  • The Company has been working over the last couple of weeks to reduce its issued and outstanding shares.
  • The Forty Million (40,000,000) additional share cancelation makes a total of Two Hundred and Two Million (202,000,000) total shares canceled during the month of August alone.
  • This brings the current issued and outstanding down to 236,982,816.
  • Jermain Strong, Branded Legacy, Inc.s CEO, concluded, We are excited to bring yet another share cancelation.

Branded Legacy, Inc. Cancels Another 60 Million Common Shares

Retrieved on: 
Wednesday, August 10, 2022
CBDX, Vitamin, Share repurchase, Injury, Inflammation, Forward-looking statement, GLOBE, Mineral, Technology, Sleep, Private Securities Litigation Reform Act, Quick response manufacturing, BLEG, LLC, Brand legacy, Method, Marketing, Sino-Japanese Journalist Exchange Agreement, Engineering, Company, Spike, Acquisition, Ageing, Athlete, Organic acid, CBD, OTCQB, Quickness, Antioxidant, OTC Markets Group, Common stock, NMN, Coffee, Dietary supplement

Orlando, FL, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it canceled sixty million (60,000,000) common shares.

Key Points: 
  • Orlando, FL, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it canceled sixty million (60,000,000) common shares.
  • Jermain Strong, Branded Legacy, Inc.s CEO, concluded, We are pleased to announce consecutive exchange agreements.
  • We stand by our boards decision of a share buyback program to help improve shareholder value
    Branded Legacy, Inc. is still working on additional shares of Common Stock to cancel.
  • Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated.

Branded Legacy, Inc. Announces Cancelation of 102 Million Common Shares

Retrieved on: 
Tuesday, August 9, 2022
CBDX, Vitamin, Share repurchase, Injury, Inflammation, Forward-looking statement, GLOBE, Mineral, Technology, Sleep, Private Securities Litigation Reform Act, BLEG, Hemp, Board, LLC, Brand legacy, Method, MOQ, Marketing, Sino-Japanese Journalist Exchange Agreement, Engineering, Small business, Company, Spike, Athlete, Organic acid, CBD, OTCQB, Antioxidant, OTC Markets Group, Common stock, Coffee, Dietary supplement, Risk management

To achieve this goal, the Company has negotiated exchange agreements with previous employees to eliminate 23% of its issued and outstanding shares.

Key Points: 
  • To achieve this goal, the Company has negotiated exchange agreements with previous employees to eliminate 23% of its issued and outstanding shares.
  • Jermain Strong, Branded Legacy, Inc.s CEO, concluded, We are doing everything in our power to get this Company growing.
  • This 102 million share reduction lowers the issued and outstanding by over 23% to 336,982,816.
  • The Board is also discussing a share buyback program to help improve shareholder value
    Branded Legacy, Inc. is also working on an additional Eighty Million (80,000,000) plus shares of Common Stock to cancel.

Post Holdings Announces Debt-for-Equity Exchange and Offering of BellRing Brands Common Stock by Selling Stockholders

Retrieved on: 
Tuesday, August 9, 2022
Telephone, J.P. Morgan & Co., Securities Act of 1933, U.S. Securities and Exchange Commission, 2nd Floor (Nina song), Forward-looking statement, NYSE, Broadridge Financial Solutions, GLOBE, Securities Exchange Act of 1934, Sale, Prospectus, LLC, Goldman Sachs, Post Holdings, Barclays, Varick Street, Company, Attention, Commission, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Morgan Stanley, Sino-Japanese Journalist Exchange Agreement, Post, Security (finance)

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST) (the Company or Post) today announced an underwritten offering (the offering) of 14,800,000 shares of common stock (the offering shares) of BellRing Brands, Inc. (BellRing).

Key Points: 
  • ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST) (the Company or Post) today announced an underwritten offering (the offering) of 14,800,000 shares of common stock (the offering shares) of BellRing Brands, Inc. (BellRing).
  • Immediately after giving effect to the Debt-for-Equity Exchange, the Company will retain 4,597,339 shares of common stock of BellRing.
  • The offering is being made pursuant to a registration statement filed by BellRing with the U.S. Securities and Exchange Commission (the Commission).
  • BellRing is not selling any shares of common stock of BellRing and will not receive any proceeds from the sale of the offering shares in the offering.

Constellation Brands Announces Exchange of Canopy Notes

Retrieved on: 
Thursday, June 30, 2022
Constellation, SEDAR, Annual report, Corona (beer), Wine, Constellation Brands, Love, Grupo Modelo, GLOBE, Price, Exercise, Ownership, Beer, Exchange, Floor, Bangladesh Securities and Exchange Commission, Sino-Japanese Journalist Exchange Agreement, Indian stock exchange, NYSE, Nasdaq, CPG, Market, News, Canopy Growth, Chronicle of the Market Prices, Security (finance), Canopy, Note

The transaction forms part of an exchange by Canopy of an aggregate of approximately C$255,373,000 principal amount of Notes held by certain holders, including Greenstar (together, the Exchanging Holders) into Common Shares.

Key Points: 
  • The transaction forms part of an exchange by Canopy of an aggregate of approximately C$255,373,000 principal amount of Notes held by certain holders, including Greenstar (together, the Exchanging Holders) into Common Shares.
  • As the Exchange Price is not yet known, the actual number of Common Shares issuable to Greenstar pursuant to the Exchange Agreement is not yet known.
  • Assuming the Market Price and current exchange rates, Greenstar would receive an aggregate of 21,929,914 Common Shares, representing approximately 5.4% of the currently issued outstanding Common Shares.
  • Prior to the Second Supplement and entering the Exchange Agreement, Greenstar, individually, held 37,753,802 Common Shares, no warrants and C$200,000,000 principal amount of Notes.

Innovative MedTech Acquires RX Vitality in a Share Exchange

Retrieved on: 
Thursday, April 28, 2022
Adult, Intention, Nursing, CEO, GLOBE, Private Securities Litigation Reform Act, BLUE, Technology, Growth, OTC, Traction, Company, Sumathi Best Television Current Reporting Award, Acquisition, Exercise, Vitality, Medtech, Sino-Japanese Journalist Exchange Agreement, Board, IMTH, Central Waqf Council, SEC, RX, Health, Cryptocurrency, Risk management, Security (finance)

BLUE ISLAND, Ill., April 28, 2022 (GLOBE NEWSWIRE) -- Innovative MedTech, Inc. (the "Company")(OTC: IMTH ), a provider of health and wellness services, today announced that it has signed a share exchange agreement to acquire RX Vitality, Inc. (RX Vitality), a media and finance advisory company, in a stock transaction.

Key Points: 
  • BLUE ISLAND, Ill., April 28, 2022 (GLOBE NEWSWIRE) -- Innovative MedTech, Inc. (the "Company")(OTC: IMTH ), a provider of health and wellness services, today announced that it has signed a share exchange agreement to acquire RX Vitality, Inc. (RX Vitality), a media and finance advisory company, in a stock transaction.
  • The Company remains committed to its strategy of growing its health and wellness services, as well as its healthcare digital wallet under development.
  • Pursuant to the Share Exchange Agreement, the shareholders of RX Vitality sold 100% of their outstanding shares of RX Vitality to the Company in exchange for receiving 5,500,000 shares of Company common stock and 50,000 shares of Series A Convertible Preferred Stock (which preferred stock is convertible into 5,000,000 shares of common stock).
  • SarahCare offers seniors daytime care and activities ranging from exercise and medical needs daily to nursing care and salon services.

Global Technologies, Ltd and Tersus Power, Inc. Enter into Definitive Share Exchange Agreement

Retrieved on: 
Friday, March 11, 2022
Hydrogen, Safety, Intention, Party, Rights, Company, Common stock, Securities and Exchange Commission (Nigeria), SMR, Attica Market and Main Historic District, LOI, SSA Global Technologies, OTC Markets Group, Judgement, Acquisition, Intellectual property, Sino-Japanese Journalist Exchange Agreement, GLOBE, Security (finance), Date, MOM, Metal, Letter, SEC, Record, FINRA, Online shopping, Oil, Tropidozineus tersus, CBD, Exchange

On March 9, 2022, the Company entered into a Share Exchange Agreement (the Exchange Agreement) with Tersus Power and the Tersus Shareholders.

Key Points: 
  • On March 9, 2022, the Company entered into a Share Exchange Agreement (the Exchange Agreement) with Tersus Power and the Tersus Shareholders.
  • Under the terms of the Exchange Agreement, at Closing the Company shall deliver to the Tersus Shareholders a to-be-determined pro-rata number of shares of the Companys Class A Common Stock for each one (1) share of Tersus common stock held by the Tersus Shareholder (the Exchange Ratio).
  • Either party may terminate the Exchange Agreement if a Closing has not occurred on or before June 30, 2022.
  • Michael Rosen, Presidentof Tersus Power, stated It is gratifying to move from the LOI stage of the merger with GTLL into todays announced Definitive Share Exchange Agreement, in preparation for next step filings with the SEC.

Averox Inc. Takes New Name and Goes on a Mission

Retrieved on: 
Wednesday, January 19, 2022
Transfer, Income, Article, CBS Dream Team, BH, GLOBE, Solution, OTC Markets Group, Subsidiary, Bangladesh Securities and Exchange Commission, History, Time, OTC, Industry, Confusion, Articles of incorporation, Private Securities Litigation Reform Act, Company, Sino-Japanese Journalist Exchange Agreement, X-Men, LLC, Security (finance), Airline, Custodian

To reduce confusion by disassociating ourselves from the private software developer that is still using the Averox name.

Key Points: 
  • To reduce confusion by disassociating ourselves from the private software developer that is still using the Averox name.
  • Averox/ Innovation Nation Inc. history is explained in a September 27, 2021 legal opinion letter filed with OTC Markets Group.
  • As a result of the merger, the Company amended its Articles of Incorporation to change its name to Averox, Inc.
  • Investors may find additional information regarding Innovation Nation Inc/ Averox Inc. at the OTC Markets website at http://www.sec.gov, or the companys website, https://www.otcmarkets.com

Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes

Retrieved on: 
Wednesday, December 15, 2021
African, LIBOR, Company, ADS, VWAP, Severe acute respiratory syndrome coronavirus 2, Term loan, Growth, Credit, COVID-19, HIV, NASDAQ, Review, Note, Sino-Japanese Journalist Exchange Agreement, Health, Intention, ADSS, Warrant, WHO, World Health Organization, American depositary receipt, Term, Tax, Security (finance), Pharmaceutical industry

The Groups cash balance at the end of Q3, 2021 was $27.5m compared to $28.6m at the end of Q2, 2021.

Key Points: 
  • The Groups cash balance at the end of Q3, 2021 was $27.5m compared to $28.6m at the end of Q2, 2021.
  • The Term Loan does not require any amortization, and the entire unpaid balance will be payable upon maturity.
  • The Term Loan can be repaid, in part or in full, at a premium before the end of the four-year term.
  • In connection with the Term Loan the Company has agreed, subject to drawdown of the Term Loan, to issue warrants (the Warrants) exercisable for 2,500,000 of the Companys ADSs to Perceptive.

Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021

Retrieved on: 
Monday, November 1, 2021
Pregnancy, Kidney, Atrial fibrillation, Drug, Anemia, Abdominal pain, Upper respiratory tract infection, Cholesterol, Bronchitis, Twitter, Simvastatin, Tendon rupture, Fetus, Gout, Patient, Clinical trial, Spasm, Moyamoya disease, U.S. Securities and Exchange Commission, Rotator cuff, Sino-Japanese Journalist Exchange Agreement, Risk, Back pain, Pravastatin, Lactation, Disease, Uric acid, Pharmacokinetics, Diet, Safety, Rupture, Esperies, Pain, Shoulder, Mortality, Achilles tendon, Pharmaceutical industry, Dietary supplement

Limitations of Use: The effect of bempedoic acid on cardiovascular morbidity and mortality has not been determined.

Key Points: 
  • Limitations of Use: The effect of bempedoic acid on cardiovascular morbidity and mortality has not been determined.
  • Monitor for signs and symptoms of hyperuricemia, and initiate treatment with urate-lowering drugs as appropriate.
  • Tendon Rupture: Bempedoic acid is associated with an increased risk of tendon rupture or injury.
  • The inclusion of forward-looking statements should not be regarded as a representation by ESPERION that any of these results will be achieved.